One positive side effect of the fast rollout of the COVID vaccine might be that the FDA has learned to be more "agile" and have more "regulatory flexibility."
Health care leaders entered 2021 with increased anxiety, facing uncertainty brought on by the coronavirus pandemic and a new presidential administration. To help navigate some of most significant challenges, several high-ranking members of the Avalere Health team participated in a live webinar Jan. 7, "2021 Avalere Healthcare Industry Outlook: Clearing the Path."
Topics during the one-hour panel discussion ranged from the likely impact of a U.S. Congress with a Democratic majority to the emerging COVID-19 vaccines and therapeutics marketplace.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
